Baxter Bros Inc’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.18M | Sell |
13,815
-1,990
| -13% | -$177K | 0.15% | 84 |
|
|
2025
Q4 | $1.25M | Sell |
15,805
-754
| -5% | -$59.1K | 0.14% | 80 |
|
|
2025
Q3 | $1.32M | Sell |
16,559
-1,871
| -10% | -$160K | 0.15% | 79 |
|
|
2025
Q2 | $1.68M | Sell |
18,430
-843
| -4% | -$77K | 0.2% | 69 |
|
|
2025
Q1 | $1.81M | Buy |
19,273
+480
| +3% | +$43K | 0.24% | 66 |
|
|
2024
Q4 | $1.71M | Sell |
18,793
-738
| -4% | -$70.4K | 0.22% | 67 |
|
|
2024
Q3 | $2.03M | Sell |
19,531
-2,050
| -9% | -$209K | 0.26% | 64 |
|
|
2024
Q2 | $2.09M | Sell |
21,581
-420
| -2% | -$38.7K | 0.27% | 61 |
|
|
2024
Q1 | $1.98M | Sell |
22,001
-759
| -3% | -$64.3K | 0.25% | 65 |
|
|
2023
Q4 | $1.81M | Sell |
22,760
-895
| -4% | -$67.3K | 0.25% | 68 |
|
|
2023
Q3 | $1.68M | Sell |
23,655
-2,742
| -10% | -$205K | 0.26% | 67 |
|
|
2023
Q2 | $2.03M | Buy |
26,397
+280
| +1% | +$21.7K | 0.3% | 62 |
|
|
2023
Q1 | $1.96M | Sell |
26,117
-200
| -0.8% | -$14.9K | 0.31% | 61 |
|
|
2022
Q4 | $2.07M | Sell |
26,317
-805
| -3% | -$60.4K | 0.34% | 59 |
|
|
2022
Q3 | $1.91M | Sell |
27,122
-839
| -3% | -$65.8K | 0.34% | 58 |
|
|
2022
Q2 | $2.24M | Hold |
27,961
| – | – | 0.4% | 53 |
|
|
2022
Q1 | $2.12M | Sell |
27,961
-1,516
| -5% | -$120K | 0.32% | 54 |
|
|
2021
Q4 | $2.52M | Sell |
29,477
-759
| -3% | -$59.3K | 0.36% | 53 |
|
|
2021
Q3 | $2.29M | Sell |
30,236
-2,268
| -7% | -$180K | 0.37% | 54 |
|
|
2021
Q2 | $2.64M | Sell |
32,504
-4
| -0% | -$327 | 0.42% | 51 |
|
|
2021
Q1 | $2.56M | Sell |
32,508
-198
| -0.6% | -$15.5K | 0.44% | 50 |
|
|
2020
Q4 | $2.8M | Sell |
32,706
-799
| -2% | -$66.1K | 0.53% | 46 |
|
|
2020
Q3 | $2.58M | Sell |
33,505
-1,029
| -3% | -$78.5K | 0.56% | 44 |
|
|
2020
Q2 | $2.53M | Sell |
34,534
-1,519
| -4% | -$108K | 0.59% | 42 |
|
|
2020
Q1 | $2.39M | Sell |
36,053
-1,769
| -5% | -$125K | 0.62% | 44 |
|
|
2019
Q4 | $2.6M | Sell |
37,822
-981
| -3% | -$66.9K | 0.54% | 45 |
|
|
2019
Q3 | $2.85M | Sell |
38,803
-3,717
| -9% | -$270K | 0.65% | 41 |
|
|
2019
Q2 | $3.05M | Sell |
42,520
-2,388
| -5% | -$170K | 0.7% | 39 |
|
|
2019
Q1 | $3.08M | Sell |
44,908
-3,214
| -7% | -$208K | 0.72% | 38 |
|
|
2018
Q4 | $2.86M | Sell |
48,122
-3,136
| -6% | -$196K | 0.78% | 37 |
|
|
2018
Q3 | $3.43M | Sell |
51,258
-1,879
| -4% | -$125K | 0.82% | 38 |
|
|
2018
Q2 | $3.44M | Sell |
53,137
-1,411
| -3% | -$92.3K | 0.93% | 34 |
|
|
2018
Q1 | $3.91M | Sell |
54,548
-2,706
| -5% | -$195K | 1.07% | 30 |
|
|
2017
Q4 | $4.32M | Sell |
57,254
-6,186
| -10% | -$452K | 1.18% | 28 |
|
|
2017
Q3 | $4.62M | Sell |
63,440
-1,000
| -2% | -$72.1K | 1.33% | 23 |
|
|
2017
Q2 | $4.78M | Sell |
64,440
-297
| -0.5% | -$22.1K | 1.44% | 22 |
|
|
2017
Q1 | $4.74M | Sell |
64,737
-796
| -1% | -$55.7K | 1.48% | 20 |
|
|
2016
Q4 | $4.29M | Sell |
65,533
-976
| -1% | -$66.9K | 1.38% | 24 |
|
|
2016
Q3 | $4.93M | Sell |
66,509
-2,497
| -4% | -$185K | 1.67% | 18 |
|
|
2016
Q2 | $5.05M | Buy |
+69,006
| New | +$4.91M | 1.77% | 18 |
|
|
2015
Q4 | $4.82M | Sell |
72,377
-4,287
| -6% | -$285K | 1.79% | 17 |
|
|
2015
Q3 | $5.01M | Hold |
76,664
| – | – | 1.84% | 17 |
|
|
2015
Q2 | $5.01M | Sell |
76,664
-2,354
| -3% | -$160K | 1.84% | 17 |
|
|
2015
Q1 | $5.48M | Sell |
79,018
-97
| -0.1% | -$6.7K | 1.99% | 16 |
|
|
2014
Q4 | $5.47M | Sell |
79,115
-547
| -0.7% | -$36.9K | 1.98% | 18 |
|
|
2014
Q3 | $5.2M | Buy |
79,662
+1,642
| +2% | +$108K | 2.02% | 17 |
|
|
2014
Q2 | $5.32M | Sell |
78,020
-2,415
| -3% | -$162K | 2.19% | 14 |
|
|
2014
Q1 | $5.22M | Buy |
80,435
+53
| +0.1% | +$3.34K | 2.37% | 13 |
|
|
2013
Q4 | $5.24M | Sell |
80,382
-210
| -0.3% | -$13.4K | 2.46% | 12 |
|
|
2013
Q3 | $4.78M | Buy |
80,592
+72
| +0.1% | +$4.27K | 2.61% | 12 |
|
|
2013
Q2 | $4.61M | Buy |
+80,520
| New | +$4.78M | 2.8% | 10 |
|
Other funds holding CL
VCM
DAM
VPM
Baxter Bros Inc's CL Position: Q1 2026 in Review
Baxter Bros Inc reduced its Colgate-Palmolive (CL) stake by 13% in Q1 2026, selling an estimated $177K and leaving 13,815 shares worth $1.18M. The position accounts for 0.15% of the portfolio, ranked #84.
Baxter Bros Inc first reported a position in CL in Q2 2013 and has held it in 51 quarters since. The position peaked at $5.48M in Q1 2015. 1,945 funds tracked by Wall St. Rank hold CL as of Q1 2026.
- Baxter Bros Inc held 13,815 shares of Colgate-Palmolive worth $1.18M as of Q1 2026.
- Baxter Bros Inc sold 1,990 Colgate-Palmolive shares in Q1 2026, an estimated $177K.
- Colgate-Palmolive made up 0.15% of Baxter Bros Inc's portfolio in Q1 2026, its #84 holding.
- Baxter Bros Inc first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 51 quarters since.
- Baxter Bros Inc's Colgate-Palmolive position peaked at $5.48M in Q1 2015.
- 1,945 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.
Based on Baxter Bros Inc's 13F filing for Q1 2026, filed 28 Apr 2026.